As part of the settlement announced this week, Boehringer agreed to pay the sum in back pay and interest to the women at the facility that makes biological animal vaccines.
The Labor Department alleges the employees — who work as scientists, technicians and technical administrators — were paid less base compensation than male employees at the company’s animal health unit. According to STAT, the alleged wage discrimination occurred after an audit in 2015, when Boehringer Ingelheim was a federal contractor.
In addition to back pay, Boehringer Ingelheim has also agreed to ensure the company’s pay policies and procedures are free from discrimination and provide training to workers who oversee compensation decisions, the Labor Department said.
Boehringer Ingelheim cooperated with federal officials to resolve the issues, does not admit liability and denies the allegations, according to the Labor Department.
More articles on legal and regulatory issues:
Ex-CEO gets 3 years in prison for healthcare fraud
Defamation lawsuit accuses New Jersey hospital of ‘bowing to Twitter mob’
Ex-New Jersey hospital workers charged with embezzlement
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.